Selective Removal of Undifferentiated Embryonic Stem Cells from Differentiation Cultures Through HSV1 Thymidine Kinase and Ganciclovir Treatment

Stem Cell Reviews and Reports

Volumn 6, Issue 3, 2010, Pages 450-461

  Naujok, Ortwin ^a   Kaldrack, Joanna ^a   Taivankhuu, Terbish ^a   Jörns, Anne ^a   Lenzen, Sigurd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Embryonic stem cells; Ganciclovir treatment; Insulin producing cells; Teratoma

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; THYMIDINE KINASE;

ARTICLE; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; ENZYMOLOGY; EVALUATION; GENETICS; HERPES SIMPLEX VIRUS 1; HUMAN; METABOLISM; PROMOTER REGION; SUICIDE TRANSGENE;

ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CLONE CELLS; EMBRYONIC STEM CELLS; GANCICLOVIR; GENES, TRANSGENIC, SUICIDE; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 1, HUMAN; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; THYMIDINE KINASE;

HUMAN HERPESVIRUS 1;

EID: 77955851661     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9148-z     Document Type: Article

References (31)

1. D'Amour, K. A., Bang, A. G., Eliazer, S., et al. (2006). Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology, 24, 1392-1401.
2. Jiang, J., Au, M., Lu, K., et al. (2007). Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells, 25, 1940-1953.
3. Naujok, O., Francini, F., Jörns, A., & Lenzen, S. (2008). An efficient experimental strategy for mouse embryonic stem cell differentiation and separation of a cytokeratin-19-positive population of insulin-producing cells. Cell Proliferation, 41, 607-624.
4. Kroon, E., Martinson, L. A., Kadoya, K., et al. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology, 26, 443-452.
5. Basma, H., Soto-Gutierrez, A., Yannam, G. R., et al. (2009). Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology, 136, 990-999.
6. Wobus, A. M., Wallukat, G., & Hescheler, J. (1991). Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation, 48, 173-182.
7. Ben-Hur, T., Idelson, M., Khaner, H., et al. (2004). Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells, 22, 1246-1255.
8. Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences of the United States of America, 78, 7634-7638.
9. Shih, C. C., Forman, S. J., Chu, P., & Slovak, M. (2007). Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. Stem Cells and Development, 16, 893-902.
10. Knoepfler, P. S. (2009). Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells, 27, 1050-1056.
11. Schuldiner, M., Itskovitz-Eldor, J., & Benvenisty, N. (2003). Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells, 21, 257-265.
12. Choo, A. B., Tan, H. L., Ang, S. N., et al. (2008). Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells, 26, 1454-1463.
13. Tan, H. L., Fong, W. J., Lee, E. H., Yap, M., & Choo, A. (2009). mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells, 27, 1792-1801.
14. Niwa, H., Miyazaki, J., & Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics, 24, 372-376.
15. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
16. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W., & Kemler, R. (1985). The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. Journal of Embryology and Experimental Morphology, 87, 27-45.
17. Naujok, O., Francini, F., Picton, S., Bailey, C. J., Lenzen, S., & Jörns, A. (2009). Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo. Diabetes & Metabolism Research Review, 25, 464-476.
18. Naujok, O., Francini, F., Picton, S., Jörns, A., Bailey, C. J., & Lenzen, S. (2008). A new experimental protocol for preferential differentiation of mouse embryonic stem cells into insulin-producing cells. Cell Transplantation, 17, 1231-1242.
19. Ensenat-Waser, R., Santana, A., Vicente-Salar, N., et al. (2006). Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking. In vitro Cellular & Developmental Biology. Animal, 42, 115-123.
20. Chalmers, D., Ferrand, C., Apperley, J. F., et al. (2001). Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene. Molecular Therapy, 4, 146-148.
21. Vandesompele, J., De Preter, K., Pattyn, F., et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology, 3, 34. 1-34. 11.
22. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
23. Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156.
24. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
25. Cao, F., Drukker, M., Lin, S., et al. (2007). Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells, 9, 107-117.
26. Schieke, S. M., Ma, M., Cao, L., et al. (2008). Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. Journal of Biological Chemistry, 283, 28506-28512.
27. Chambers, I., & Tomlinson, S. R. (2009). The transcriptional foundation of pluripotency. Development, 136, 2311-2322.
28. Wildner, O., Morris, J. C., Vahanian, N. N., Ford, H., Jr., Ramsey, W. J., & Blaese, R. M. (1999). Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Gene Therapy, 6, 57-62.
29. Rainov, N. G., & Ren, H. (2003). Clinical trials with retrovirus mediated gene therapy-what have we learned? Journal of Neurooncology, 65, 227-236.
30. Li, Z. B., Zeng, Z. J., Chen, Q., Luo, S. Q., & Hu, W. X. (2006). Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer. BMC Cancer, 6, 66.
31. Hewitt, Z., Priddle, H., Thomson, A. J., Wojtacha, D., & McWhir, J. (2007). Ablation of undifferentiated human embryonic stem cells: exploiting innate immunity against the Gal alpha1-3Galbeta1-4GlcNAc-R (alpha-Gal) epitope. Stem Cells, 25, 10-18.